These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 32216563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis.
    Zhang Y, Yang L, Shi J, Lu Y, Chen X, Yang Z.
    Biomed Res Int; 2020; 2020():3040839. PubMed ID: 32337237
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
    Zhuang L, Yang Z, Meng Z.
    Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
    [Abstract] [Full Text] [Related]

  • 5. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y, Zhang J, Li L, Li S, Yang Z.
    Biosci Rep; 2020 Feb 28; 40(2):. PubMed ID: 31990034
    [Abstract] [Full Text] [Related]

  • 6. Squalene epoxidase (SQLE) promotes the growth and migration of the hepatocellular carcinoma cells.
    Sui Z, Zhou J, Cheng Z, Lu P.
    Tumour Biol; 2015 Aug 28; 36(8):6173-9. PubMed ID: 25787749
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G, Li XP, Niu CY, Liu ML, Yan QQ, Fan LP, Li Y, Zhang KL, Gao J, Qian MR, He N, Mi M.
    Gene; 2020 Jun 05; 742():144549. PubMed ID: 32184169
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.
    World J Gastroenterol; 2019 Jan 14; 25(2):220-232. PubMed ID: 30670911
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY, Kim JH, Yang JW, Kim J, Kim B, Park CK.
    Cancer Res Treat; 2016 Jul 14; 48(3):1065-73. PubMed ID: 26511806
    [Abstract] [Full Text] [Related]

  • 19. Absent in melanoma 1-like (AIM1L) serves as a novel candidate for overall survival in hepatocellular carcinoma.
    Zhou W, Zhang Y, Zhang S, Yang Z.
    Bioengineered; 2021 Dec 14; 12(1):2750-2762. PubMed ID: 34130591
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.